Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725392 | SCV000336581 | uncertain significance | not provided | 2015-10-15 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000283983 | SCV000710939 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Gly27093Gly in exon 282 of TTN: This variant is not expected to have clinical significance because it does not alter an amino acid residue nor is it located within the splice consensus sequence. It has been identified in 4/125304 Europea n chromosomes by the Genome Aggregation Database (qnomAD; http://gnomad.broadins titute.org/; dbSNP rs371678936). |
Gene |
RCV000725392 | SCV000730425 | likely benign | not provided | 2019-01-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001078767 | SCV000765495 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356378 | SCV002656833 | likely benign | Cardiovascular phenotype | 2020-05-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486803 | SCV004240157 | likely benign | Cardiomyopathy | 2022-08-31 | criteria provided, single submitter | clinical testing |